Luna R, Sales K, Bonifacio L, Figueredo L, Shelite T, Nogueira F
Parasit Vectors. 2025; 18(1):2.
PMID: 39773298
PMC: 11705694.
DOI: 10.1186/s13071-024-06633-7.
Mahachi K, Ozanne M, Bourdeau P, Sarquis J, Kontowicz E, Solano-Gallego L
Parasit Vectors. 2024; 17(1):545.
PMID: 39734221
PMC: 11684067.
DOI: 10.1186/s13071-024-06631-9.
Miro G, Segarra S, Ceron J, Ferrer L, Solano-Gallego L, Montell L
PLoS Negl Trop Dis. 2024; 18(12):e0012712.
PMID: 39700303
PMC: 11698568.
DOI: 10.1371/journal.pntd.0012712.
Molnar A, Murillo-Picco A, Jimenez-Fortunato C, Solano-Gallego L
Animals (Basel). 2024; 14(23).
PMID: 39682429
PMC: 11640336.
DOI: 10.3390/ani14233464.
Pantaleo V, Furlanello T, Campigli M, Ventura L, Solano-Gallego L
Vet Sci. 2024; 11(11).
PMID: 39591291
PMC: 11598865.
DOI: 10.3390/vetsci11110517.
Evaluation of urinary podocin and nephrin as markers of podocyturia in dogs with leishmaniosis.
Pantaleo V, Furlanello T, Carli E, Ventura L, Solano-Gallego L
Parasit Vectors. 2024; 17(1):423.
PMID: 39380100
PMC: 11462908.
DOI: 10.1186/s13071-024-06510-3.
Serum and urinary monocyte chemoattractant protein-1 as markers of inflammation and renal damage in dogs with naturally occurring leishmaniosis.
Pantaleo V, Furlanello T, Ventura L, Solano-Gallego L
Parasit Vectors. 2024; 17(1):366.
PMID: 39210379
PMC: 11363603.
DOI: 10.1186/s13071-024-06432-0.
First detection of Leishmania major in dogs living in an endemic area of zoonotic cutaneous leishmaniasis in Tunisia.
Maurelli M, Zribi L, Fayala N, Manzillo V, Balestrino I, Hamdi N
Parasit Vectors. 2024; 17(1):333.
PMID: 39123245
PMC: 11312402.
DOI: 10.1186/s13071-024-06395-2.
Critically Appraised Topic on Canine Leishmaniosis: Does Treatment with Antimonials and Allopurinol Have the Same Clinical and Clinicopathological Efficacy as Treatment with Miltefosine and Allopurinol, after One Month of Treatment?.
Garcia M, Ferrer L, Ordeix L
Vet Sci. 2024; 11(6).
PMID: 38921978
PMC: 11209642.
DOI: 10.3390/vetsci11060231.
Treatment and Healing of Leishmaniasis in a Wolf in Semi-Captivity Regime from an Educational Center of Zamora Province (Spain).
Merino-Goyenechea J, Palacios-Alberti J, Yanes-Martinez T, Martinez-Valladares M, Balana-Fouce R
Animals (Basel). 2024; 14(10).
PMID: 38791654
PMC: 11117261.
DOI: 10.3390/ani14101436.
Comparative Study of a Novel Lateral Flow Rapid Test with Conventional Serological Test Systems for the Diagnosis of Canine Leishmaniosis in Croatia and Brazil.
Mahdavi R, Martinkovic F, Shams-Eldin H, Pereira I, Reis A, Latz A
Pathogens. 2024; 13(2).
PMID: 38392847
PMC: 10892489.
DOI: 10.3390/pathogens13020109.
Joint Bayesian longitudinal models for mixed outcome types and associated model selection techniques.
Seedorff N, Brown G, Scorza B, Petersen C
Comput Stat. 2024; 38(4):1735-1769.
PMID: 38292019
PMC: 10825672.
DOI: 10.1007/s00180-022-01280-x.
The immune response in canine and human leishmaniasis and how this influences the diagnosis- a review and assessment of recent research.
Ivanescu L, Andronic B, Grigore-Hristodorescu S, Martinescu G, Mindru R, Miron L
Front Cell Infect Microbiol. 2023; 13:1326521.
PMID: 38149009
PMC: 10749942.
DOI: 10.3389/fcimb.2023.1326521.
Development of a multi-epitope vaccine candidate for leishmanial parasites applying immunoinformatics and approaches.
Jyotisha , Qureshi R, Qureshi I
Front Immunol. 2023; 14:1269774.
PMID: 38035118
PMC: 10684680.
DOI: 10.3389/fimmu.2023.1269774.
A blinded, randomized and controlled multicenter clinical trial to assess the efficacy and safety of Leisguard as an immunotherapeutic treatment for healthy Leishmania infantum-seropositive dogs.
Baxarias M, Donato G, Mateu C, Salichs M, Homedes J, Miro G
Parasit Vectors. 2023; 16(1):344.
PMID: 37794502
PMC: 10552330.
DOI: 10.1186/s13071-023-05903-0.
Prevalence and incidence of canine visceral leishmaniasis and its clinical-immunological features in an endemic area of the Brazilian Amazon.
Carneiro L, Lima L, Campos M, Vasconcelos Dos Santos T, Ramos P, Laurenti M
Vet Med Sci. 2023; 9(6):2463-2474.
PMID: 37654028
PMC: 10650335.
DOI: 10.1002/vms3.1218.
Retrospective Long-Term Evaluation of Miltefosine-Allopurinol Treatment in Canine Leishmaniosis.
Gizzarelli M, Manzillo V, Inglese A, Montagnaro S, Oliva G
Pathogens. 2023; 12(7).
PMID: 37513711
PMC: 10384837.
DOI: 10.3390/pathogens12070864.
Seroprevalence in Dogs: Comparing Shelter and Domestic Communities.
Afonso P, Coelho A, Quintas H, Cardoso L
Animals (Basel). 2023; 13(14).
PMID: 37508129
PMC: 10376450.
DOI: 10.3390/ani13142352.
Serological survey of Leishmania infantum in apparently healthy dogs in different areas of Spain.
Baxarias M, Mateu C, Miro G, Solano-Gallego L
Vet Med Sci. 2023; 9(5):1980-1988.
PMID: 37438910
PMC: 10508519.
DOI: 10.1002/vms3.1172.
Feline leishmaniosis: hematological and biochemical analysis.
Silva D, Alves M, Spada J, Leonel J, Vioti G, Benassi J
Rev Bras Parasitol Vet. 2023; 32(2):e003823.
PMID: 37377321
PMC: 10321720.
DOI: 10.1590/S1984-29612023035.